marijuana stocks news

Easton Pharmaceuticals Inc. (EAPH)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014
Total Revenue –   –   –   67  
Cost of Revenue 44
Gross Profit –   –   –   24  
Operating Expenses
Research Development 45 26 93 104
Selling General and Administrative 371 48 28 57
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (416) (74) (121) (137)
Income from Continuing Operations
Total Other Income/Expenses Net 19 2 40 89
Earnings Before Interest And Taxes (397) (71) (81) (48)
Interest Expense
Income Before Tax (397) (71) (81) (48)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (397) (71) (81) (48)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (397) (71) (81) (48)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (397) (71) (81) (48)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HEXO Corp (HEXO) strengthens leadership team, appoints Donald Courtney as Chief Operating Officer

HEXO strengthens leadership team, appoints Donald Courtney as Chief Operating Officer HEXO…

Biome Grow Inc. (BIOIF) (BIO.CN) Announces Appointment of Rita Theil to its Board of Directors

Biome Grow Inc. Announces Appointment of Rita Theil to its Board of…

$CARA to Sponsor Symposium and Present Posters at PAINWeek

Cara Therapeutics to Sponsor Symposium and Present Posters at PAINWeek Pain experts…

Emblem Corp. (EMMBF) and Canntab Therapeutics Announce Health Canada Approval for R&D

Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based…